These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 3679541

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Active and passive immunization to protect against antibiotic associated caecitis in hamsters.
    Fernie DS, Thomson RO, Batty I, Walker PD.
    Dev Biol Stand; 1983; 53():325-32. PubMed ID: 6873474
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Oral Immunization with Nontoxigenic Clostridium difficile Strains Expressing Chimeric Fragments of TcdA and TcdB Elicits Protective Immunity against C. difficile Infection in Both Mice and Hamsters.
    Wang Y, Wang S, Bouillaut L, Li C, Duan Z, Zhang K, Ju X, Tzipori S, Sonenshein AL, Sun X.
    Infect Immun; 2018 Nov; 86(11):. PubMed ID: 30150259
    [Abstract] [Full Text] [Related]

  • 7. Treatment and Prevention of Recurrent Clostridium difficile Infection with Functionalized Bovine Antibody-Enriched Whey in a Hamster Primary Infection Model.
    Heidebrecht HJ, Weiss WJ, Pulse M, Lange A, Gisch K, Kliem H, Mann S, Pfaffl MW, Kulozik U, von Eichel-Streiber C.
    Toxins (Basel); 2019 Feb 06; 11(2):. PubMed ID: 30736358
    [Abstract] [Full Text] [Related]

  • 8. Mucosal Antibodies to the C Terminus of Toxin A Prevent Colonization of Clostridium difficile.
    Hong HA, Hitri K, Hosseini S, Kotowicz N, Bryan D, Mawas F, Wilkinson AJ, van Broekhoven A, Kearsey J, Cutting SM.
    Infect Immun; 2017 Apr 06; 85(4):. PubMed ID: 28167669
    [Abstract] [Full Text] [Related]

  • 9. Enzyme immunoassay for detection of antibody to toxins A and B of Clostridium difficile.
    Viscidi RP, Yolken RH, Laughon BE, Bartlett JG.
    J Clin Microbiol; 1983 Aug 06; 18(2):242-7. PubMed ID: 6619280
    [Abstract] [Full Text] [Related]

  • 10. Clostridium difficile chimeric toxin receptor binding domain vaccine induced protection against different strains in active and passive challenge models.
    Tian JH, Glenn G, Flyer D, Zhou B, Liu Y, Sullivan E, Wu H, Cummings JF, Elllingsworth L, Smith G.
    Vaccine; 2017 Jul 24; 35(33):4079-4087. PubMed ID: 28669616
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Protection against Clostridium difficile infection in a hamster model by oral vaccination using flagellin FliC-loaded pectin beads.
    Bruxelle JF, Tsapis N, Hoys S, Collignon A, Janoir C, Fattal E, Péchiné S.
    Vaccine; 2018 Sep 25; 36(40):6017-6021. PubMed ID: 30172633
    [Abstract] [Full Text] [Related]

  • 15. Development of a recombinant toxin fragment vaccine for Clostridium difficile infection.
    Karczewski J, Zorman J, Wang S, Miezeiewski M, Xie J, Soring K, Petrescu I, Rogers I, Thiriot DS, Cook JC, Chamberlin M, Xoconostle RF, Nahas DD, Joyce JG, Bodmer JL, Heinrichs JH, Secore S.
    Vaccine; 2014 May 19; 32(24):2812-8. PubMed ID: 24662701
    [Abstract] [Full Text] [Related]

  • 16. Immunization of hamsters against Clostridium difficile infection using the Cwp84 protease as an antigen.
    Péchiné S, Denève C, Le Monnier A, Hoys S, Janoir C, Collignon A.
    FEMS Immunol Med Microbiol; 2011 Oct 19; 63(1):73-81. PubMed ID: 21707776
    [Abstract] [Full Text] [Related]

  • 17. Serum antitoxin antibodies mediate systemic and mucosal protection from Clostridium difficile disease in hamsters.
    Giannasca PJ, Zhang ZX, Lei WD, Boden JA, Giel MA, Monath TP, Thomas WD.
    Infect Immun; 1999 Feb 19; 67(2):527-38. PubMed ID: 9916055
    [Abstract] [Full Text] [Related]

  • 18. Transcutaneous immunization with Clostridium difficile toxoid A induces systemic and mucosal immune responses and toxin A-neutralizing antibodies in mice.
    Ghose C, Kalsy A, Sheikh A, Rollenhagen J, John M, Young J, Rollins SM, Qadri F, Calderwood SB, Kelly CP, Ryan ET.
    Infect Immun; 2007 Jun 19; 75(6):2826-32. PubMed ID: 17371854
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A novel fusion protein containing the receptor binding domains of C. difficile toxin A and toxin B elicits protective immunity against lethal toxin and spore challenge in preclinical efficacy models.
    Tian JH, Fuhrmann SR, Kluepfel-Stahl S, Carman RJ, Ellingsworth L, Flyer DC.
    Vaccine; 2012 Jun 13; 30(28):4249-58. PubMed ID: 22537987
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.